Dobutamine stress cardiac magnetic resonance imaging to detect myocardial ischemia in women

Preventive Cardiology

Volumn 11, Issue 3, 2008, Pages 135-140

  Raman, Subha V ^a   Donnally, Michael R ^a   McCarthy, Beth ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DOBUTAMINE; CARDIOTONIC AGENT; DIAGNOSTIC AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOBUTAMINE STRESS CARDIAC MAGNETIC RESONANCE IMAGING; ELECTROCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HEART RATE; HEART STRESS; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; THORAX PAIN; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; EXERCISE TEST; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY;

CARDIOTONIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DOBUTAMINE; EXERCISE TEST; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; MYOCARDIAL ISCHEMIA; REPRODUCIBILITY OF RESULTS;

EID: 50549096369     PISSN: 1520037X     EISSN: 17517141     Source Type: Journal    
DOI: 10.1111/j.1751-7141.2008.08243.x     Document Type: Article

References (40)

1. Heart Disease and Stroke Statistics - 2005 Update. Dallas, TX: American Heart Association; 2005.
2. Cannon RO 3rd, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation. 1992;85:883-892.
3. Sullivan AK, Holdright DR, Wright CA, et al. Chest pain in women: clinical, investigative, and prognostic features. BMJ. 1994;308:883-886.
4. Cavusoglu Y, Entok E, Timuralp B, et al. Regional distribution and extent of perfusion abnormalities, and the lung to heart uptake ratios during exercise thallium-201 SPECT imaging in patients with cardiac syndrome X. Can J Cardiol. 2005;21:57-62.
5. Samuel RS, Hausdorff JM, Wei JY. Congestive heart failure with preserved systolic function: Is it a woman's disease? Womens Health Issues. 1999;9:219-222.
6. Lindenfeld J, Krause-Steinrauf H, Salerno J. Where are all the women with heart failure? J Am Coll Cardiol. 1997;30:1417-1419.
7. Stromberg A, Martensson J. Gender differences in patients with heart failure. Eur J Cardiovasc Nurs. 2003;2:7-18.
8. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429-1435.
9. McDermott MM, Feinglass J, Sy J, et al. Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: Clinical characteristics and drug therapy. Am J Med. 1995;99:629-635.
10. Nuclear Medicine Census Market Summary Report. Des Plaines, IL: IMV; 2003.
11. Hendel RC, Wackers FJ, Berman DS, et al. American Society of Nuclear Cardiology consensus statement: Reporting of radionuclide myocardial perfusion imaging studies. J Nucl Cardiol. 2003;10:705-708.
12. Mieres JH, Shaw LJ, Arai A, et al; Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111:682-696.
13. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation. 1999;100:1697-1702.
14. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: Comparison with dobutamine stress echocardiography. Circulation. 1999;99(6):763-770.
15. Nagel E, Lorenz C, Baer F, et al. Stress cardiovascular magnetic resonance: Consensus panel report. J Cardiovasc Magn Reson. 2001;3:267-281.
16. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
17. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440-1463.
18. Lauer MS, Pashkow FJ, Snader CE, et al. Gender and referral for coronary angiography after treadmill thallium testing. Am J Cardiol. 1996;78:278-283.
19. Shaw LJ, Heller GV, Travin MI, et al. Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain. Economics of Noninvasive Diagnosis (END) Study Group. J Nucl Cardiol. 1999;6:559-569.
20. Mosca L, Grundy S, Judelson D, et al. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology. J Am Coll Cardiol. 1999;33:1751-1755.
21. Cushman M, Legault C, Barrett-Connor E, et al. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/ Progestin Interventions (PEPI) Study. Circulation. 1999;100:717-722.
22. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med. 1996;334(20):1311-1315.
23. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA Guidelines for Exercise Testing: A report of the ACC/AHA task force on practice guidelines. J Am Coll Cardiol. 1997;30(1):260-315.
24. Rosano GM, Sarrel PM, Poole-Wilson PA, et al. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 1993;342:133-136.
25. Morise AP, Dalal JN, Duval RD. Value of a simple measure of estrogen status for improving the diagnosis of coronary artery disease in women. Am J Med. 1993;94:491-496.
26. Hlatky MA, Pryor DB, Harrell FE Jr, et al. Factors affecting sensitivity and specificity of exercise electrocardiography. Multivariable analysis. Am J Med. 1984;77:64-71.
27. Baer FM, Crnac J, Schmidt M, et al. Magnetic resonance pharmacological stress for detecting coronary disease. Comparison with echocardiography. Herz. 2000;25:400-408.
28. Sommer T, Hofer U, Omran H, et al. Stress cine MRI for detection of coronary artery disease [in German]. Rofo. 2002;174(5):605-613.
29. Kuijpers D, Ho K, van Dijkman P, et al. Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia with the use of myocardial tagging. Circulation. 2003;107:1592-1597.
30. Paestsch I, Jahnke C, Wahl A, et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation. 2004;110:835-842.
31. Kelle S, Nagel E, Fleck E. Cardiovascular MRT-replacement of diagnostic invasive coronary angiography? Internist (Berl). 2006;47:18-27.
32. Kuijpers D. Diagnosis of coronary artery disease with dobutamine-stress MRI. Eur Radiol. 2005;15:B48-B51.
33. Bree D, Wollmuth J, Cupps B, et al. Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy. Circulation. 2006;114:I33-I36.
34. Al-Saadi N, Nagel E, Gross M, et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation. 2000;101:1379-1383.
35. Ennis DB, Epstein FH, Kellman P, et al. Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging. Magn Reson Med. 2003;50:638-642.
36. Paelinck BP, de Roos A, Bax JJ, et al. Feasibility of tissue magnetic resonance imaging: A pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol. 2005;45:1109-1116.
37. Kuijer JP, Marcus JT, Gotte MJ, et al. Three-dimensional myocardial strains at end-systole and during diastole in the left ventricle of normal humans. J Cardiovasc Magn Reson. 2002;4:341-351.
38. Aletras AH, Freidlin RZ, Navon G, et al. AIR-SPAMM: Alternative inversion recovery spatial modulation of magnetization for myocardial tagging. J Magn Reson. 2004;166:236-245.
39. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med. 2002;346:1948-1953.
40. Hundley WGMT, Neagle C, Hamilton C, et al. Magnetic resonance imaging determination of cardiac prognosis. Circulation. 2002;106:2328-2333.